Proximal 4p deletion syndrome is characterized clinically by mental retardation, minor dysmorphic facial features, and is occasionally complicated with epilepsy. More than 20 cases of proximal 4p deletion syndrome have been reported, but the causative gene(s) remain elusive. We describe here a 2-year-old female patient with a common manifestation of proximal 4p deletion syndrome and infantile epileptic encephalopathy possessing a de novo balanced translocation t(4;13)(p15.2;q12.13). The patient was diagnosed as infantile spasms at 9 months of age. She presented with dysmorphic facial features and global developmental delay, compatible with proximal 4p deletion syndrome. Using fluorescence in situ hybridization, we determined the translocation breakpoint at 4p15.2 to be withinRBPJ. RBPJ is a transcription factor in the Notch/RBPJ signaling pathway, playing a crucial role in the developing human brain, and particularly telencephalon development. Our findings, combined with those of previous studies, strongly suggest that RBPJ is causative for proximal 4p deletion syndrome and epilepsy in this case.
Introduction
Deletions involving the proximal portion of human chromosome 4p15 result in a clinically distinct syndrome characterized by variable degrees of intellectual disability, unusual faces, and minor dysmorphic features [1] [2] [3] . More than 20 cases of proximal 4p deletion have been reported. The critical region for proximal 4p deletion syndrome has been localized to 4p15.2-15.33, but the causative gene remains elusive.
Infantile spasms (IS), also known as West syndrome, is the most frequent type of epileptogenic encephalopathy. Various types of epileptic spasms, hypsarrhythmia on electroencephalography (EEG), and psychomotor deterioration constitute the basis for a diagnosis of IS. IS is not a nosological entity but rather constitutes a heterogeneous group of conditions that share this clinical triad. Several genetic abnormalities have been identified among the diverse possible causes of IS. Although the number of mutations identified is small, it gives rise to the intriguing possibility that genetic abnormalities underlie a proportion of IS etiology.
